Institutional shares held 33.4 Million
72.5K calls
56.5K puts
Total value of holdings $728M
$1.58M calls
$1.23M puts
Market Cap $12.8B
586,827,008 Shares Out.
Institutional ownership 5.69%
# of Institutions 175


Latest Institutional Activity in FMS

Top Purchases

Q3 2024
Fiduciary Management Inc Shares Held: 6.56M ($143M)
Q3 2024
Integral Health Asset Management, LLC Shares Held: 450K ($9.81M)
Q3 2024
Arrowstreet Capital, Limited Partnership Shares Held: 279K ($6.09M)
Q3 2024
Two Sigma Investments, LP Shares Held: 139K ($3.02M)
Q3 2024
Moran Wealth Management, LLC Shares Held: 233K ($5.09M)

Top Sells

Q3 2024
Goldman Sachs Group Inc Shares Held: 669K ($14.6M)
Q3 2024
O'Shaughnessy Asset Management, LLC Shares Held: 36.5K ($795K)
Q3 2024
Triasima Portfolio Management Inc. Shares Held: 20.6K ($448K)
Q3 2024
Dodge & Cox Shares Held: 4.17M ($90.9M)
Q3 2024
Citadel Advisors LLC Shares Held: 68.3K ($1.49M)

About FMS

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.


Insider Transactions at FMS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on FMS

Follow Fresenius Medical Care AG & Co. KGaA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FMS shares.

Notify only if

Insider Trading

Get notified when an Fresenius Medical Care Ag & Co. K Ga A insider buys or sells FMS shares.

Notify only if

News

Receive news related to Fresenius Medical Care AG & Co. KGaA

Track Activities on FMS